Anika Therapeutics (ANIK) Interest & Investment Income (2010 - 2026)
Anika Therapeutics (ANIK) reported Interest & Investment Income of $667000.0 for Q1 2026, up 60.72% year-over-year from $415000.0 in Q1 2025, and up 465.25% quarter-over-quarter from $118000.0 in Q4 2025.
Anika Therapeutics (ANIK) Interest & Investment Income (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has 17 years of Interest & Investment Income data on file, last reported at $667000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $667000.0, up 60.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 million (down 7.59% YoY), and the FY2025 annual result was $1.7 million, down 25.37% from the prior year.
- Interest & Investment Income climbed to $667000.0 in Q1 2026 per ANIK's latest filing, from $118000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $997000.0 in Q3 2025 and troughed at -$154000.0 in Q1 2022.
- A 5-year average of $453764.7 and a median of $539000.0 in 2023 frame the typical range for Interest & Investment Income.
- On a YoY basis, Interest & Investment Income climbed as much as 1008.33% in 2022 and fell as far as 258.14% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at $276000.0 in 2022, then soared by 109.06% to $577000.0 in 2023, then gained by 28.94% to $744000.0 in 2024, then sank by 84.14% to $118000.0 in 2025, then surged by 465.25% to $667000.0 in 2026.
- Business Quant data shows ANIK's Interest & Investment Income at $667000.0 in Q1 2026, $118000.0 in Q4 2025, and $997000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Anika Therapeutics | 200.80 Mn | 134.01 Mn | 19.00 Mn | 667,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 667,000.00 |
| Dec 31, 2025 | 118,000.00 |
| Sep 30, 2025 | 997,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Mar 31, 2025 | 415,000.00 |
| Dec 31, 2024 | 744,000.00 |
| Sep 30, 2024 | 406,000.00 |
| Jun 30, 2024 | 595,000.00 |
| Mar 31, 2024 | 592,000.00 |
| Dec 31, 2023 | 577,000.00 |
| Sep 30, 2023 | 635,000.00 |
| Jun 30, 2023 | 561,000.00 |
| Mar 31, 2023 | 539,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 436,000.00 |
| Jun 30, 2022 | 96,000.00 |
| Mar 31, 2022 | -154,000.00 |
| Dec 31, 2021 | -47,000.00 |
| Sep 30, 2021 | -48,000.00 |
| Jun 30, 2021 | -50,000.00 |